Terns Pharmaceuticals, Inc. (TERN) Insider Trading

Name: Terns Pharmaceuticals, Inc. (TERN) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (May 5, 2026): Robert Azelby (Director): Disposition to Issuer of 90,000 shares.

Get alerted when insiders trade TERN

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta